1996
DOI: 10.1038/nm0896-859
|View full text |Cite
|
Sign up to set email alerts
|

Ventricular remodeling: Hype or hope?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
9
0

Year Published

1998
1998
2009
2009

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…Indeed, no outcome data from the patients in the present study are available. McCarthy, 5 Starling et al, 6 and Pashkow 7 have reported preliminary outcome data after PLV in a series of 53 patients, with a 1-year mortality rate of Ϸ6%. However, 20% to 30% of their patients had subsequent worsening of heart failure, with 15% to 20% requiring mechanical circulatory assistance.…”
Section: Selected Abbreviations and Acronymsmentioning
confidence: 98%
See 1 more Smart Citation
“…Indeed, no outcome data from the patients in the present study are available. McCarthy, 5 Starling et al, 6 and Pashkow 7 have reported preliminary outcome data after PLV in a series of 53 patients, with a 1-year mortality rate of Ϸ6%. However, 20% to 30% of their patients had subsequent worsening of heart failure, with 15% to 20% requiring mechanical circulatory assistance.…”
Section: Selected Abbreviations and Acronymsmentioning
confidence: 98%
“…2,3 Furthermore, patient outcome remains variable, and details concerning patient selection, the surgical technique itself, and long-term outcome are just beginning to emerge. [1][2][3][4][5][6][7] The objectives of this study were (1) to enhance understanding of the immediate effects of PLV on LV performance in patients with severe heart failure by use of relatively load-independent measures and (2) to identify potential clinical or histological variables that may be associated with improvements in LV performance.…”
mentioning
confidence: 99%
“…1) Current treatment modalities, such as angioplasty and thrombolytic agents, are far from adequate. [2][3][4] Cardiac tissue engineering is one of the new therapies for myocardial infarction. 5) In native heart tissue, cardiac cells metabolize very actively, and cell density is very high (abut 1.0 × 10 8 /cm 3 ).…”
mentioning
confidence: 99%
“…The procedure nevertheless carries multiple risks: 20% of patients die while awaiting a donor heart; 10-20% die during the first year after a transplant; and there are ongoing risks of rejection, infection, coronary artery disease, and cancers. 28 The availability of xenografts from transgenic pigs or baboons could reduce the waiting list mortality, but would carry the additional risk of infection by latent animal viruses 3,8 ; the other risks and costs would remain. Ventricular reduction carries a high perioperative mortality and an adequate assessment awaits the outcome of properly conducted clinical trials.…”
mentioning
confidence: 99%
“…Ventricular reduction carries a high perioperative mortality and an adequate assessment awaits the outcome of properly conducted clinical trials. 28 Mechanical artificial hearts will continue to be used mainly as a bridge to transplant; furthermore, even if all the problems of bio-and hemocompatibility were solved, the continuous presence of an external power supply may pose an unacceptable psychological challenge to the patient in long-term use. 37 Against this background, a surgical approach to cardiac assist that is based on the use of a patient's own skeletal muscle is an attractive prospect.…”
mentioning
confidence: 99%